Shares of Pfizer offer a yield above 7% at recent prices. Pfizer is a pharmaceutical giant that has raised its dividend every ...

Lululemon has sued Costco, alleging the retailer sells low-cost athleisure apparel knockoffs that unlawfully infringe ...

Biocon Ltd. plans to file for regulatory approvals of generic versions of Novo Nordisk A/S’s Ozempic and Wegovy in key ...

The Bengaluru-based company is seeking approval of generic Ozempic by September from Canadian authorities, and also in some ...

Kerala's public health system progress, high private health expenditure, rising treatment costs, and urgent recommendations ...

Incyte's new CEO, Bill Meury, signals a potential strategic pivot toward M&A, leveraging his biopharma acquisition experience ...

Biocon share price gained 2.5 per cent after reports suggested that the company is planning to file for generic versions of ...

"Big pharma braces for revenue headwinds as patent expiries loom" was originally created and published by Pharmaceutical ...

More than 700 ETFs launched last year, including ones that hold crypto or make leveraged bets on individual stocks like ...

Collegium's new ADHD drugs may allow the company to grow revenues faster and pay off debt faster. Click here to find out why ...

There's expectations weight-loss drug Wegovy will eventually be funded publicly, according to experts. It's become available ...